Andrew J. Muzyk, PharmD
- 2Articles
- 5.2KReads1
- 2015Active
- 8Collaborators
- 6Citations2
About
Andrew J. Muzyk, PharmD, has published research focusing on the impact of FDA drug safety communications on prescribing patterns, specifically examining zolpidem dosing and citalopram use. His work addresses clinical considerations in the management of depression and patient care. Muzyk's articles appeared in 2015 in Psychiatrist.com (The Journal of Clinical Psychiatry and The Primary Care Companion for CNS Disorders).
Publications
Evaluation of Changes in Citalopram Prescribing Patterns Following a US Food and Drug Administration Alert: A Retrospective Cohort Study
February 12, 2015
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
